Treatment Options for Infantile Hemangioma (Hemangioma or Strawberry Hemangioma)
Infantile hemangiomas, also known as strawberry hemangiomas, are the most common non-cancerous tumors in children. While most of these hemangiomas are small and do not cause any complications, a small percentage of hemangioma cases of can cause problems that affect how the body works, leading to permanent changes in appearance, or even become life-threatening.
The objective of treatment for Infantile Hemangioma is to control the growth and potential complications of the tumor. The treatment aims to achieve the following goals:
- Slow progression: The primary objective is to slow down or inhibit the growth of the hemangioma. If left untreated, some hemangiomas can grow rapidly and cause complications such as ulcers, bleeding, infection, and functional impairment.
- Prevent complications: Treatment helps prevent potential life-threatening complications and permanent disfigurement that can arise from hemangiomas in certain situations.
- Control symptoms: The treatment also focuses on managing symptoms associated with the hemangioma, such as pain and discomfort.
It's important to note that while treatment can effectively control the growth and symptoms of Infantile Hemangioma, it may not necessarily cure the condition. In many cases, the tumor naturally regresses over time without any intervention. However, treatment can help manage the condition and minimize any long-term effects or complications that may arise from the hemangioma.
The recommended potential treatments for Infantile Hemangioma include:
Medication:
- Oral propranolol: This is the first-line therapy for high-risk infantile hemangiomas. Propranolol is a medication that belongs to a class called beta-blockers, and it helps to shrink the hemangioma by reducing blood flow to the affected area. It is usually administered as an oral solution. The recommended dosage starts at 0.6 mg/kg twice daily and may be increased gradually over time.
- Topical timolol: This medication can be offered to patients with small infantile hemangiomas and a low risk of complications. Timolol is applied directly to the skin and helps to reduce blood flow to the hemangioma.
- Vincristine: Vincristine is a chemotherapy medication that may be used in severe cases of infantile hemangiomas that do not respond to other treatments.
- Steroids: Steroids can be used either topically or systemically to help reduce inflammation and shrink the hemangioma.
Laser therapy:
- Laser therapy can be used as a single treatment option or as a complementary treatment for residual lesions. It is primarily indicated for superficial hemangiomas. Laser therapy uses concentrated beams of light to target and shrink the blood vessels in the hemangioma.
Other therapeutic procedures:
- Sclerotherapy: In cases where standard treatments are not effective, sclerotherapy may be considered. Sclerotherapy involves injecting a medication into the hemangioma to shrink it.
- Surgical resection: In some cases, surgical removal of the hemangioma may be necessary, especially if it poses a risk of injury to other tissues or organs.
It's important to note that treatment recommendations may vary depending on the size, location, and risk factors associated with the infantile hemangioma. It is always recommended to consult with a healthcare professional who has experience treating hemangiomas to determine the most appropriate treatment option for each individual case.